This finding is largely attributable to the fact that monoallelic mutations need to cooperate with other driver mutations or secondary TP53 dysfunction to maintain malignancy, which alone is not sufficient to cause MDS (23). This evidence concerns the gene TP53 and myelodysplastic syndrome.